BioMarin Pharmaceutical Statistics

Total Valuation

LON:0HNC has a market cap or net worth of GBP 10.30 billion. The enterprise value is 9.87 billion.

Market Cap	10.30B
Enterprise Value	9.87B

Important Dates

The last earnings date was Friday, February 21, 2025.

Earnings Date	Feb 21, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+2.67%
Shares Change (QoQ)	-0.29%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	178.59M

Valuation Ratios

The trailing PE ratio is 30.21.

PE Ratio	30.21
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	2.48
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 18.72, with an EV/FCF ratio of 25.35.

EV / Earnings	28.95
EV / Sales	4.37
EV / EBITDA	18.72
EV / EBIT	21.88
EV / FCF	25.35

Financial Position

The company has a current ratio of 5.33, with a Debt / Equity ratio of 0.11.

Current Ratio	5.33
Quick Ratio	2.96
Debt / Equity	0.11
Debt / EBITDA	0.89
Debt / FCF	1.22
Interest Coverage	45.02

Financial Efficiency

Return on equity (ROE) is 8.05% and return on invested capital (ROIC) is 5.78%.

Return on Equity (ROE)	8.05%
Return on Assets (ROA)	5.15%
Return on Invested Capital (ROIC)	5.78%
Return on Capital Employed (ROCE)	8.93%
Revenue Per Employee	670,280
Profits Per Employee	100,254
Employee Count	3,401
Asset Turnover	0.41
Inventory Turnover	1.13

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -22.53% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-22.53%
50-Day Moving Average	65.10
200-Day Moving Average	74.46
Relative Strength Index (RSI)	67.14
Average Volume (20 Days)	1,469

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.92

Income Statement

In the last 12 months, LON:0HNC had revenue of GBP 2.28 billion and earned 340.96 million in profits. Earnings per share was 1.77.

Revenue	2.28B
Gross Profit	1.22B
Operating Income	455.47M
Pretax Income	432.74M
Net Income	340.96M
EBITDA	532.49M
EBIT	455.47M
Earnings Per Share (EPS)	1.77

Full Income Statement

Balance Sheet

The company has 908.77 million in cash and 475.38 million in debt, giving a net cash position of 433.39 million.

Cash & Cash Equivalents	908.77M
Total Debt	475.38M
Net Cash	433.39M
Net Cash Per Share	n/a
Equity (Book Value)	4.52B
Book Value Per Share	23.69
Working Capital	2.10B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 457.57 million and capital expenditures -68.23 million, giving a free cash flow of 389.33 million.

Operating Cash Flow	457.57M
Capital Expenditures	-68.23M
Free Cash Flow	389.33M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 53.49%, with operating and profit margins of 19.98% and 14.96%.

Gross Margin	53.49%
Operating Margin	19.98%
Pretax Margin	18.98%
Profit Margin	14.96%
EBITDA Margin	23.36%
EBIT Margin	19.98%
FCF Margin	17.08%

Dividends & Yields

LON:0HNC does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.67%
Shareholder Yield	-2.67%
Earnings Yield	3.31%
FCF Yield	3.78%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

LON:0HNC has an Altman Z-Score of 7.99.

Altman Z-Score	7.99
Piotroski F-Score	n/a